KBC Securities - Hyloris Pharmaceuticals (HYL) Hyloris Valacyclovir oral suspension deal with Rosemont, appoints new CFO

Report

KBC Securities

Jacob Mekhael

Hyloris Valacyclovir oral suspension deal with Rosemont, appoints new CFO

Hyloris announced an exclusive license and supply agreement with Rosemont Pharmaceuticals for its Valacyclovir oral suspension in the US. In addition, the company appointed a new CFO, Christophe Maréchal, who previously served as CFO and co-CEO of Mithra. We reiterate our € 5 TP and HOLD rating.

09/12/2024 1 EN

Underlying

Hyloris Pharmaceuticals

See profile

BE0974363955 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Jacob Mekhael

Other Reports on these Companies

KBC Securities

Morning Notes : OPTI BB, DIE BB, CMBT BB, GLPG NA, HYL BB, UCB BB, CTPNV NA

: OPTI BB, DIE BB, CMBT BB, GLPG NA, HYL BB, UCB BB, CTPNV NA

December 9, 2024 December 9, 2024 1 EN

KBC Securities

Morning Notes : BAR BB, HYL BB, SIP BB, EKOP BB, AUTL US

: BAR BB, HYL BB, SIP BB, EKOP BB, AUTL US

October 17, 2024 October 17, 2024 1 EN

Cofinimmo FY24 divestment plan completed, all office periphery assets sold

Yesterday Cofinimmo announced the completion of its EUR 215.0m FY24 divestment target. 2 offices are divested and 5 healthcare assets in Belgium and The Netherlands. This comes after Cofinimmo announced 85% of its divestment target was completed last week. At the time, the exact projects were however unknown and the share price did not move on the back of the positive news. All 3 Belgian elderly care assets were leased to Armonea and so it could be a package deal. The Parklane campus was the last office building of Cofinimmo in Brussels periphery. With the updated investment plan given last w...

December 20, 2024 December 20, 2024 1 EN

Hilde Van Boxstael ... (+6)

Hilde Van Boxstael
Jacob Mekhael
Lynn Hautekeete
Thomas Vranken
Wim Hoste
Wim Lewi

Morning Notes : AED BB, COFB BB, TESB BB, ONWD BB, ZEAL DC

: AED BB, COFB BB, TESB BB, ONWD BB, ZEAL DC

December 20, 2024 December 20, 2024 1 EN

Wim Hoste

Wim Hoste

Tessenderlo Tough end markets hurt earnings momentum

We have lowered our adjusted EBITDA forecasts for FY24-26 by a 12-15% range following the FY24 adjusted EBITDA guidance reduction from a 5-10% decline to a 15-20% drop. Whilst business conditions in a number of end markets are clearly challenging, Tessenderlo is still generating a sizeable free cash flow, which we estimate at c. 120m for FY24 and which represents a FCF yield of c 10%. The company is using its solid balance sheet and FCF to buy back own shares. Despite the disappointing earnings momentum, we consider valuation to be attractive enough from maintaining our Accumulate rating with ...

December 20, 2024 December 20, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Hyloris Valacyclovir oral suspension deal with Rosemont, appoints new CFO

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : OPTI BB, DIE BB, CMBT BB, GLPG NA, HYL BB, UCB BB, CTPNV NA

Morning Notes : BAR BB, HYL BB, SIP BB, EKOP BB, AUTL US

Cofinimmo FY24 divestment plan completed, all office periphery assets sold

Morning Notes : AED BB, COFB BB, TESB BB, ONWD BB, ZEAL DC

Tessenderlo Tough end markets hurt earnings momentum

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe